Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001567619-21-021618 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-03 | 2021-12-01 | TXG | McAnear Justin J. | CFO | S - Sale+OE | $147.75 | -10.0K | 38.9K | -20% | -$1.48M |
| D | 2021-12-03 | 2021-12-01 | TXG | McAnear Justin J. | CFO | M - OptEx | $5.04 | +10.0K | 48.8K | +26% | +$50.4K |
| D | 2021-12-03 | 2021-12-01 | TXG | McAnear Justin J. | CFO | M - OptEx | $0.00 | -10.0K | 360.2K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-12-01 | S | D | 100 | $155.55 | 38,819 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-12-01 | M | A | 10,000 | $5.04 | 48,819 | D | — | — | |
| 3 | Common | Class A Common Stock | 2021-12-01 | S | D | 2,462 | $145.54 | 46,357 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $145.01 to $145.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-12-01 | S | D | 1,536 | $146.49 | 44,821 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $146.03 to $147.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-12-01 | S | D | 2,700 | $147.62 | 42,121 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $147.06 to $148.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2021-12-01 | S | D | 1,302 | $148.48 | 40,819 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $148.13 to $149.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Class A Common Stock | 2021-12-01 | S | D | 600 | $149.41 | 40,219 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $149.14 to $150.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 8 | Common | Class A Common Stock | 2021-12-01 | S | D | 500 | $150.71 | 39,719 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $150.16 to $150.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 9 | Common | Class A Common Stock | 2021-12-01 | S | D | 300 | $151.31 | 39,419 | D | — | — | (F8) This transaction was executed in multiple trades at prices ranging from $151.26 to $151.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 10 | Common | Class A Common Stock | 2021-12-01 | S | D | 300 | $151.80 | 39,119 | D | — | — | (F9) This transaction was executed in multiple trades at prices ranging from $151.50 to $152.36. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 11 | Common | Class A Common Stock | 2021-12-01 | S | D | 200 | $153.86 | 38,919 | D | — | — | (F10) This transaction was executed in multiple trades at prices ranging from $153.58 to $154.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 12 | Derivative | Stock Option (right to buy) | 2021-12-01 | M | D | 10,000 | $0.00 | 360,159 | D | $5.04 · — to 2028-11-02 | 10,000 Class A Common Stock | (F11) This option, originally for 600,000 shares, of which 239,841 shares have been exercised, vested as to 1/4th of the shares on October 8, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |